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A b s t r a c t
Introduction: The aim of this multicenter, prospective study was to evaluate the
long-term prognostic value of low-dose dobutamine stress echocardiography
(LDDSE) in patients with aortic stenosis (AS) and depressed left ventricular (LV)
function.
Material and methods: The study group comprised 39 patients (34 male, mean
age 59 ±13 years) with AS (peak gradient > 25 mm Hg), LV ejection fraction (LVEF)
≤ 45% and low transaortic gradient (peak gradient ≤ 45 mm Hg, mean gradient
≤ 35 mm Hg). The qualification for subsequent therapeutic procedures was
based on generally accepted indications. All patients underwent LDDSE and
coronary angiography. Twelve months after LDDSE patients underwent control
resting echocardiography and clinical evaluation.
Results: Twenty-seven (69.2%) patients had preserved contractile reserve. In
this subgroup, true-severe AS was diagnosed in 12 patients, whereas pseudo-
severe AS was found in 15 patients. Nine patients with true-severe AS, 2 patients
with pseudo-severe AS and 7 patients without contractile reserve were referred
for surgical treatment. The independent risk factors of death during follow-up
were: aortic valve area (AVA) at peak stress < 0.8 cm2 (OR 1.4; p = 0.003) and
LVEF at rest < 35% (OR 6.8; p = 0.05). The independent risk factors of compos-
ite end-point (death or myocardial infarctions or pulmonary edema) were: AVA
at stress < 0.8 cm2 (OR 4.0; p = 0.03), absence of AVA increase during LDDSE
(OR 5.7; p = 0.005), absence of contractile reserve (OR 4.5; p = 0.01) and pres-
ence of significant CAD (OR 6.9; p = 0.02). 
Conclusions: In patients with AS and depressed LVEF, LDDSE is a useful tool for
long-term risk stratification.
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Introduction
Aortic stenosis (AS) with coexisting left ven-
tricular (LV) dysfunction presents both diagnostic
and therapeutic challenges. In this scenario, low-
dose dobutamine stress echocardiography (LDDSE)
enables the detection of contractile reserve [1].
Based on LDDSE results patients with preserved
LV contractile reserve can be further classified into
at least two important subgroups: those with true-
severe AS, who will benefit from surgical treat-
ment, and those with pseudo-severe AS, who can
remain on medical treatment [2, 3]. Other treat-
ment options, such as transcatheter aortic valve
implantation or cardiac resynchronization thera-
py, have also been recently described in these
patients [4-6] The choice of the best approach in
patients without contractile reserve remains
a matter of debate [7]. 
Stress echocardiography has been demonstrat-
ed to have prognostic value in patients with AS and
impaired LV function [8, 9]. However, the available
data regarding utility of LDDSE as a tool for long-
term risk stratification are still limited. The aims of
this multicenter and prospective study were: to
evaluate the long-term prognostic value of LDDSE
in patients with AS and depressed LV function with
regard to clinical and echocardiographic outcome
variables, and to compare the effects of treatment
strategy on the LV remodeling process.
Material and methods
Patient population
We prospectively studied 39 patients with AS
(peak gradient > 25 mm Hg), depressed LV systolic
function (LV ejection fraction, LVEF ≤ 45%) and 
low transaortic pressure gradient (peak gradient 
≤ 45 mm Hg and at the same time mean gradient
≤ 35 mm Hg). Exclusion criteria included: chronic
atrial fibrillation, other significant valve disease,
moderate or severe aortic regurgitation, con-
traindications to LDDSE, clinical and hemodynam-
ic instability, implanted pacemaker and poor qual-
ity of echocardiographic images at rest precluding
reliable assessment of LV contractility, valve mor-
phology and function.
Study protocol
All patients underwent LDDSE. Patients were
instructed to abstain from β-blockers and calci-
um-antagonists for at least 24 h before the test.
All other medications were continued as pre-
scribed. The qualification for subsequent coronary
angiography and further therapeutic procedures
was based on generally accepted indications and
was a decision of attending physicians, not influ-
enced by the study protocol. Twelve months after
LDDSE patients underwent control resting
echocardiography and clinical evaluation. The clin-
ical end-points included: death, myocardial infarc-
tion and significant worsening of heart failure
symptoms (pulmonary edema). The study proto-
col was approved by the Ethics Committee of our
institution and written consent was obtained from
all participants.
Low-dose dobutamine stress 
echocardiography
The standard LDDSE protocol was used for stress
echocardiography. The dobutamine dose sequence
was 5 µg/kg/min and 10 µg/kg/min, each main-
tained for 3 min with an infusion pump.
Echocardiographic images were acquired at each
stage of LDDSE (Sonos 2500 and Sonos 5500). At
each stage transaortic peak and mean gradients
were measured and aortic valve area (AVA) was
determined using the continuity equation. Left ven-
tricular wall motion was assessed visually and
scored in each of the 16 segments as normal (1),
hypokinetic (2), akinetic (3) or dyskinetic (4). Poor-
ly visible segments were excluded from the analy-
sis. Moreover, at each stage LVEF was measured
using biplane Simpson’s method. 
Based on the difference between peak and base-
line EF the patients were classified as having pre-
served contractile reserve (≥ 20% increase in LVEF)
or having no contractile reserve (< 20% increase in
LVEF). In the subgroup with preserved contractile
reserve the patients with AVA increase during
LDDSE ≤ 0.3 cm2 and AVA at peak dose of dobuta-
mine ≤ 1 cm2 were classified as having true-severe
AS, whereas the patients with > 0.3 cm2 increase
in AVA during LDDSE or AVA at peak dose of dobu-
tamine > 1 cm2 were classified as having pseudo-
severe AS. 
Statistical analysis
Continuous and categorical variables are ex -
pressed as mean ± SD and as percentages (%),
respectively. Group comparisons were obtained
for categorical variables with χ2 test and for con-
tinuous variables with one-way analysis of vari-
ance. Assessment of time-to-event data was con-
ducted by Kaplan-Meier method and survival of
different groups was compared using the log-rank
test. Additionally, the odds ratio (OR) was calcu-
lated to assess the risk of particular events. Effect
of covariates on outcomes was determined using
Cox proportional hazard regression in a stepwise
manner. Clinically relevant variables with a p val-
ue < 0.1 on univariable analysis were incorporat-
ed into the multivariable models. Value of p of less
than 0.05 was considered to indicate statistical
significance.
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Results
Characteristics of the patients
Patients’ characteristics are summarized in Table I.
The LDDSE was well tolerated – there were no
major adverse events. The baseline echocardio-
graphic data and results of LDDSE are presented in
Table II. There were 27 (69.2%) patients with pre-
served contractile reserve and 12 (30.8%) patients
without contractile reserve. In the subgroup with
preserved contractile reserve true-severe AS was
diagnosed in 12 patients, whereas pseudo-severe
AS was found in 15 patients.
All patients underwent coronary angiography.
Significant coronary artery disease (CAD) defined
as ≥ 50% stenosis was diagnosed in 21 (53.8%)
patients, including 7 (18%) patients with single-ves-
sel disease, 7 (18%) patients with two-vessel dis-
ease and 7 (18%) patients with three-vessel disease. 
Treatment strategy
All (12) patients with true severe AS were referred
for surgical treatment. However, two of them did
not consent to surgery and one died before surgery.
Therefore, 9 patients underwent aortic valve replace-
ment (AVR); two of them had concomitant coronary
artery bypass grafting (CABG). 
Thirteen patients with pseudo-severe AS were
treated pharmacologically. One of them underwent
percutaneous coronary intervention during the fol-
low-up period. The remaining 2 patients were re -
ferred for surgical treatment due to the presence
of one criterion of true severe AS (either ≤ 0.3 cm2
increase in AVA during LDDSE or AVA at peak dose
of dobutamine ≤ 1 cm2). 
Within the subgroup without contractile reserve,
7 patients underwent AVR (5 of them had conco -
mitant CABG) and 5 patients were treated phar-
macologically.
Clinical follow-up
During the follow-up period (mean duration 353
±38 days), there were 4 deaths, 3 myocardial infarc-
tions (1 fatal) and 3 cases of pulmonary edema. One
death occurred in a patient with true severe AS
awaiting surgery; there were 2 peri-operative deaths
(one in a patient with true-severe AS and one in
a patient without contractile reserve) and one death
in a patient without contractile reserve who under-
went AVR.
The independent risk factors of death were: AVA
at peak stress < 0.8 cm2 (OR 1.4; 95% CI 1.0-2.08; 
p = 0.003) and LVEF at rest < 35% (OR 6.8; 95% CI
1.0-58.4; p = 0.05).
The independent risk factors of composite end-
point (death or myocardial infarctions or pulmonary
edema) were: AVA at peak stress < 0.8 cm2 (OR 4.0;
95% CI 1.2-13.5; p = 0.03), absence of AVA increase
during LDDSE (OR 5.7; 95% CI 2.0-16.0; p = 0.005),
absence of contractile reserve (OR 4.5; 95% CI 1.3-
15.0; p = 0.01) and presence of significant CAD
(OR 6.9; 95% CI 1.0-50.0; p = 0.02) (Figure 1).
Parameter Results
Age [years] 59 ±13
Male 34 (87.2%)
Weight [kg] 77 ±11
Height [cm] 172 ±7
Body mass index [kg/m2] 26 ±3
Body surface area [m2] 1.90 ±0.15
Dyslipidemia 18 (46.2%)
Diabetes 4 (10.3%)
Hypertension 16 (41.0%)
Smoking history 13 (33.3%)
Previous myocardial infarction 4 (10.3%)
Dyspnea at rest 10 (25.6%)
Peripheral edema 4 (10.3%)
Fatigue 25 (64.1%)
History of angina 14 (35.9%)
Ventricular arrhythmia 4 (10.3%)
Dyspnea at exertion 25 (64.1%)
Atypical chest pain 8 (20.5%)
Syncope 7 (17.9%)
Vertigo 1 (2.6%)
NYHA I 5 (12.8%)
NYHA Il 18 (46.2%)
NYHA III 16 (41.0%)
Data are presented as the mean value ± SD or number (%) of patients
Table I. Study population characteristics (n = 39)
Parameter Rest Peak stress Value of p
Heart rate [bpm] 76 ±12 82 ±12 0.001
Systolic blood 136 ±24 137 ±19 0.004
pressure [mm Hg]
Diastolic blood 84 ±11 84 ±11 NS
pressure [mm Hg]
LV EF [%] 39 ±8 45.3 ±10 0.001
AVA [cm2] 0.8 ±0.2 0.99 ±0.29 NS
Mean aortic 24.0 ±5.5 31.8 ±8.5 0.001
gradient [mm Hg]
Peak aortic 37.5 ±6.4 52 ±14.2 0.001
gradient [mm Hg]
Aortic Vmax [m/s] 3.11 ±0.4 3.57 ±0.49 0.01
Data are presented as the mean value ± SD. AVA – aortic valve area,
EF – ejection fraction, LV – left ventricle
Table II. Baseline echocardiographic data and results
of LDDSE
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All survivors with true-severe AS who underwent
surgery (n = 8) improved in their functional status
by one grade according to NYHA classification. With-
in the group of survivors without contractile reserve
who underwent surgery (n = 5) 2 patients remained
in the same NYHA class, 1 patient’s status im proved
by one class, and 2 patients’ status worsened by
one class. 
Echocardiographic follow-up
Changes in echocardiographic parameters of 
the LV and aortic valve observed after 12 months
in the study group are presented in Table III. The
changes in LVEDD, LVEF and wall motion score
index (WMSI) differed significantly between the
patients treated surgically and pharmacologically
(p = 0.005, p = 0.003, and p = 0.02, respectively). 
In patients treated pharmacologically the in -
crease in LVEDD after 12 months correlated with
base line maximum velocity at rest (r = 0.73, p < 0.01)
and with WMSI at peak stress (r = 0.52, p < 0.05),
whereas the increase in peak and mean gradients
after 12 months correlated with maximum velocity
at peak stress and peak and mean gradients at
peak stress (r = 0.48-0.77; p = 0.001-0.05). When
baseline clinical characteristics were taken into con-
sideration, we found that the increase in LVEDD was
significantly more pronounced in patients aged 
≥ 65 years (p < 0.05).
In patients treated surgically the change in
LVEDD after 12 months correlated with baseline
maximum velocity at rest (r = 0.74, p < 0.01), peak
gradient at rest (r = 0.7, p < 0.05) and WMSI at rest
(r = 0.66, p < 0.05). When baseline clinical charac-
teristics were taken into consideration, we found
that the improvement in LVEF was significantly less
pronounced in patients with CAD and patients with
hypertension (p < 0.05).
Changes All Pharmacological treatment Surgical treatment
after patients
All No contractile Contractile All No contractile Contractile1 year
(n = 20) reserve reserve (n = 15) reserve reserve 
(n = 5) (n = 15) (n = 5) (n = 10)
∆ LVEF 1.1 ±4.5 –0.9 ±3.4* –2.6 ±2.0 –0.3 ±0.7 3.40 ±4.70* 1.6 ±5.1 4.9 ±4.1
∆ LVEDD –0.0 ±4.6 1.96 ±3.64† 3.70 ±4.1 1.34 ±0.9 –2.26 ±4.72† –2.4 ±3.8 –2.2 ±5.5
∆ AVA 0.30 ±0.59 –0.04 ±0.06 –0.04 ±0.06 –0.04 ±0.06 0.91 ±0.64 0.90 ±0.94 0.93 ±0.32
∆ WMSI 0.05 ±0.20 0.12 ±0.19‡ 0.17 ±0.11 0.10 ±0.20 –0.04 ±0.18‡ 0.08 ±0.08¤ –0.11 ±0.19¤
∆ Mean aortic gradient 0.3 ±8.3 4.4 ±6.8 3.5 ±2.5 4.7 ±2.0 –6.6 ±6.0 –4.9 ±6.8 –8.1 ±5.4
∆ Max aortic gradient –1.0 ±12.8 6.4 ±11.6 3.8 ±5.2 7.3 ±3.2 –8.3 ±9.0 –5.5 ±8.5 –10.6 ±9.6
∆ Vmax –0.06 ±0.52 0.20 ±0.37 0.18 ±0.21 0.20 ±0.10 –0.47 ±0.47 –0.33 ±0.39 –0.59 ±0.54
*p = 0.003, †p = 0.005, ‡p = 0.02, ¤p = 0.02
AVA – aortic valve area, EDD – end-diastolic diameter, ESD – end-systolic diameter, LV – left ventricle, WMSI – wall motion score index, ∆ – changes
from rest to peak dobutamine
Table III. Changes in echocardiographic parameters of the left ventricle and aortic valve observed after 12 months
in patients treated surgically and pharmacologically, with and without contractile reserve on LDDSE
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Figure 1. Kaplan-Meier curves for survival free from
composite end-point (death or myocardial infarctions
or pulmonary edema) in regard to presence of sig-
nificant CAD (A), contractile reserve (CR) observed
at LDDSE (B) and AVA at peak stress (C)
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Discussion
Our study shows that in patients with AS and
depressed LVEF, LDDSE is a useful tool for long-term
risk stratification. Low LVEF at rest and low AVA at
peak stress were identified as independent risk fac-
tors of death, whereas small AVA at peak stress,
lack of increase in AVA during test, absence of con-
tractile reserve and presence of CAD were inde-
pendent risk factors of composite end-point (death
or myocardial infarctions or pulmonary edema) in
long-term follow-up. Moreover, regardless of the
nature of AS, patients treated medically present an
ongoing LV remodeling process, whereas surgery is
accompanied by a reverse LV remodeling process
in survivors. 
In our study the best results were obtained in
surgically treated patients with true-severe AS and
preserved LV contractile reserve – the perioperative
mortality in this group was 11% with no further
deaths in the follow-up period. The patients who
had true-severe AS and were not operated on were
more likely to die (33%). However, in patients with-
out contractile reserve the perioperative mortality
was high (29%) and similar to the value reported
by Tribouilloy et al. [10] In echocardiographic follow-
up the best results were obtained in patients with
preserved contractile reserve who were treated sur-
gically.
The first multicenter study to demonstrate a lack
of contractile reserve on LDDSE as a risk factor of
operative and long-term mortality in patients with
low-flow low-gradient AS was published by Monin
et al. [8]. This finding was confirmed by other
reports, including the multicenter TOPAS study,
which also indicated impaired functional capacity
as measured by the Duke Activity Status Index or
6-minute walk test distance and more severe valve
stenosis as measured by projected AVA at a nor-
mal transvalvular flow rate as other significant risk
factors of poor outcome [9]. The assessment of con-
tractile reserve by dobutamine challenge has been
proved clinically useful also in combination with
invasive assessment of cardiac output and aortic
pressure gradients [11]. Therefore, in the most
recent guidelines on stenosis assessment it was
underlined that absence of contractile reserve (fail-
ure to increase stroke volume or EF by 20% of base-
line value) is a predictor of poor outcome [3]. At the
same time, the authors of the guidelines felt that
the prognostic significance of all other parameters
obtained by means of LDDSE needs to be further
examined before they can be included in recom-
mendations [3]. Our study addressed these con-
cerns by providing further data on the matter. 
We observed a significant increase in LVEF in
patients treated surgically and it was related to the
presence of significant CAD. It is concurrent with
results of previous studies [12, 13]. However, the
relationship between hypertension and change in
LVEF observed in our study has not been demon-
strated before. In our group, presence of CAD was
also an independent risk factor of composite end-
point (death or myocardial infarctions or pulmonary
edema), but it was not significantly related to mor-
tality. Similar results (no influence on survival) were
obtained by other investigators, but at the same
time previous myocardial infarction and previous
CABG were identified as independent predictors of
mortality [9, 13, 14]. 
In patients treated pharmacologically a decrease
in LVEF over a 12-month follow-up period did not
reach statistical significance, but at the same time
we observed a significant increase in LVEDD – it
was more pronounced in elderly patients, with high-
er transaortic maximum velocity at rest and with
more wall motion abnormalities (higher WMSI) at
stress. Moreover, the peak and mean gradients at
stress predicted the progression of stenosis sever-
ity (the increase in peak and mean gradients).
The main limitations of our study include the rel-
atively small size of the group and controversies that
may arise around our inclusion criteria (AS with LVEF
≤ 45%, peak transaortic gradient ≤ 45 mm Hg, mean
transaortic gradient ≤ 35 mm Hg). However, the cut-
off values are close to recently published guidelines,
which recommend the following definition for low-
flow low gradient AS: effective orifice area < 1.0 cm2,
LVEF < 40% and mean pressure gradient < 30-40
mm Hg [3]. It must be noted that the definitions and
inclusion criteria used by different investigators
studying patients with AS and depressed LVEF var-
ied greatly in the literature available at the time of
designing our study [8, 11, 13, 15]. Patients were 
followed up for a relatively short period of time 
(12 months) and we only considered clinical and
echocardiographic end-points. Another limitation is
a lack of patients undergoing other treatment tech-
niques such as transcatheter aortic valve implanta-
tion or cardiac resynchronization therapy.
In conclusion, we demonstrated that LDDSE
serves to determine contractility reserve of the LV
and severity of AS and thus is useful for prognos-
tication in patients with AS and severe systolic dys-
function of the LV. Benefits of surgery are highest
in the patients with preserved contractility reserve
and true-severe AS.
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